114 related articles for article (PubMed ID: 32726227)
1. Predicting Value of Growth Differentiation Factor 15 and Its Correlations With Atrial Fibrillation.
Zhou J; Kang Z; Liu L; Guo Y; Chen S
Heart Surg Forum; 2020 Jul; 23(4):E452-E460. PubMed ID: 32726227
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
Pol T; Hijazi Z; Lindbäck J; Alexander JH; Bahit MC; De Caterina R; Eikelboom JW; Ezekowitz MD; Gersh BJ; Granger CB; Hylek EM; Lopes R; Siegbahn A; Wallentin L
Open Heart; 2021 Mar; 8(1):. PubMed ID: 33741689
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
Tancin Lambert A; Kong XY; Ratajczak-Tretel B; Atar D; Russell D; Skjelland M; Bjerkeli V; Skagen K; Coq M; Schordan E; Firat H; Halvorsen B; Aamodt AH
Cerebrovasc Dis Extra; 2020; 10(1):11-20. PubMed ID: 32028277
[TBL] [Abstract][Full Text] [Related]
4. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
[TBL] [Abstract][Full Text] [Related]
6. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Siegbahn A; Wallentin L
Am Heart J; 2017 Aug; 190():94-103. PubMed ID: 28760218
[TBL] [Abstract][Full Text] [Related]
7. Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.
Chen M; Ding N; Mok Y; Mathews L; Hoogeveen RC; Ballantyne CM; Chen LY; Coresh J; Matsushita K
Clin Chem; 2022 Jul; 68(8):1084-1093. PubMed ID: 35762561
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Hu XF; Zhan R; Xu S; Wang J; Wu J; Liu X; Li Y; Chen L
Clin Cardiol; 2018 Jan; 41(1):34-38. PubMed ID: 29363835
[TBL] [Abstract][Full Text] [Related]
9. Low Circulating Levels of Growth Differentiation Factor-15 Before Coronary Artery Bypass Surgery May Predict Postoperative Atrial Fibrillation.
Bouchot O; Guenancia C; Kahli A; Pujos C; Malapert G; Vergely C; Laurent G
J Cardiothorac Vasc Anesth; 2015 Oct; 29(5):1131-9. PubMed ID: 25990268
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation.
Nopp S; Königsbrügge O; Kraemmer D; Pabinger I; Ay C
Eur J Intern Med; 2021 Jun; 88():35-42. PubMed ID: 33706979
[TBL] [Abstract][Full Text] [Related]
11. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
[TBL] [Abstract][Full Text] [Related]
12. Plasma growth differentiation factor-15 in patients with "lone" atrial fibrillation.
Li N; Feng Q; Yu F; Zhou J; Guo X
J Clin Lab Anal; 2022 May; 36(5):e24373. PubMed ID: 35334497
[TBL] [Abstract][Full Text] [Related]
13. Circulating Levels of Biomarkers of Cerebral Injury in Patients with Atrial Fibrillation.
Galenko O; Jacobs V; Knight S; Bride D; Cutler MJ; Muhlestein JB; Carlquist JL; Anderson JL; Knowlton KU; Jared Bunch T
Am J Cardiol; 2019 Dec; 124(11):1697-1700. PubMed ID: 31575426
[TBL] [Abstract][Full Text] [Related]
14. Influence of the matrix type over the concentration of GDF-15.
Rivera-Caravaca JM; Vílchez JA; Rodríguez-Rojas C; Albadalejo-Otón MD; Gil-Pérez P; Lopez-García C; Veliz-Martínez A; Roldán V; Marín F
J Investig Med; 2020 Dec; 68(8):1402-1404. PubMed ID: 32907909
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers: GDF-15 and risk stratification in atrial fibrillation.
Marín F; Roldán V
Nat Rev Cardiol; 2015 Jan; 12(1):8-9. PubMed ID: 25421166
[No Abstract] [Full Text] [Related]
16. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
[TBL] [Abstract][Full Text] [Related]
18. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
19. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
[TBL] [Abstract][Full Text] [Related]
20. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
